|
AEZS
|
AEterna Zentaris Inc.
|
US
|
NASDAQ
|
|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
BPTH
|
Bio-Path Holdings Inc
|
US
|
NASDAQ
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
US
|
NASDAQ
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
US
|
NASDAQ
|